Zero-length crosslinking : A breakthrough approach for evaluating target engagement in a-synuclein immunotherapy
Rochet, Jean Christophe ; Qi, Wenzhu and Kirik, Deniz LU
(2025)
In Journal of Pharmacology and Experimental Therapeutics
392(1).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/55bcb71d-1e97-421f-ab51-4a74ec313ab8
- author
- Rochet, Jean Christophe
; Qi, Wenzhu
and Kirik, Deniz
LU
- organization
- publishing date
- 2025-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Pharmacology and Experimental Therapeutics
- volume
- 392
- issue
- 1
- article number
- 100036
- publisher
- American Society for Pharmacology and Experimental Therapeutics
- external identifiers
-
- pmid:39892995
- scopus:85214537153
- ISSN
- 0022-3565
- DOI
- 10.1016/j.jpet.2024.100036
- language
- English
- LU publication?
- yes
- id
- 55bcb71d-1e97-421f-ab51-4a74ec313ab8
- date added to LUP
- 2025-03-12 16:04:31
- date last changed
- 2025-07-03 02:23:59
@misc{55bcb71d-1e97-421f-ab51-4a74ec313ab8,
author = {{Rochet, Jean Christophe and Qi, Wenzhu and Kirik, Deniz}},
issn = {{0022-3565}},
language = {{eng}},
number = {{1}},
publisher = {{American Society for Pharmacology and Experimental Therapeutics}},
series = {{Journal of Pharmacology and Experimental Therapeutics}},
title = {{Zero-length crosslinking : A breakthrough approach for evaluating target engagement in a-synuclein immunotherapy}},
url = {{http://dx.doi.org/10.1016/j.jpet.2024.100036}},
doi = {{10.1016/j.jpet.2024.100036}},
volume = {{392}},
year = {{2025}},
}